Duong Vi, Schatzman-Bone Stephanie, Shi Joe, James Kaitlyn, Weinstein Milena M
Department of Obstetrics, Gynecology, and Reproductive Biology, Division of Urogynecology, Massachusetts General Hospital, Boston, MA, USA.
Department of Obstetrics and Gynecology, Mercy Hospital, St. Louis, MO, USA.
Int Urogynecol J. 2025 Jun 16. doi: 10.1007/s00192-025-06194-y.
Minimally invasive sacrocolpopexy (SCP) with concurrent supracervical hysterectomy (SCH) has become the preferred treatment for uterovaginal prolapse over traditional open surgery. However, there is a lack of standardization in surgical materials and techniques, leading to variations in outcomes. This study aims to examine mesh-related complications in women undergoing SCP with concurrent SCH.
A retrospective cohort study was conducted within a large academic hospital system between May 2007 and December 2021. Participants who underwent SCP with concurrent SCH were included. Demographics, perioperative characteristics, and postoperative data were collected. Mesh complications were identified using CPT codes and confirmed by chart review. Parametric and nonparametric tests were used to assess differences in participant and surgical factors, with significance set at p ≤ 0.05.
A total of 603 participants were analyzed with a mean follow-up of 55 months. Most underwent laparoscopic SCP (87%), with 53% performed by minimally invasive gynecologic surgery (MIGS) and 47% performed by urogynecology and reconstructive pelvic surgery (URPS). Mesh exposure occurred in 1.2% of cases and was significantly associated with permanent multifilament braided suture use for vaginal mesh attachment (p < 0.001). All exposures occurred in surgeries performed by MIGS surgeons. No significant associations were found with smoking, menopausal status, estrogen use, primary energy instrumentation, or mesh weight. Notably, no mesh erosions were observed.
Mesh-related complications following SCP with concurrent SCH are rare. Permanent multifilament braided suture was the only factor associated with mesh exposure. Further research is needed to evaluate surgical factors and optimize techniques.
与传统开放性手术相比,微创骶骨阴道固定术(SCP)联合宫颈上子宫切除术(SCH)已成为子宫阴道脱垂的首选治疗方法。然而,手术材料和技术缺乏标准化,导致治疗结果存在差异。本研究旨在探讨接受SCP联合SCH手术的女性中与补片相关的并发症。
在2007年5月至2021年12月期间,在一家大型学术医院系统内进行了一项回顾性队列研究。纳入接受SCP联合SCH手术的参与者。收集人口统计学、围手术期特征和术后数据。使用CPT编码识别补片并发症,并通过病历审查进行确认。采用参数检验和非参数检验评估参与者和手术因素的差异,显著性设定为p≤0.05。
共分析了603名参与者,平均随访55个月。大多数人接受了腹腔镜SCP(87%),其中53%由微创妇科手术(MIGS)完成,47%由泌尿妇科和盆底重建手术(URPS)完成。1.2%的病例发生了补片暴露,并且与用于阴道补片固定的永久性多股编织缝线的使用显著相关(p<0.001)。所有暴露均发生在由MIGS外科医生进行的手术中。未发现与吸烟、绝经状态、雌激素使用、主要能量器械或补片重量有显著关联。值得注意的是,未观察到补片侵蚀。
SCP联合SCH术后与补片相关的并发症很少见。永久性多股编织缝线是与补片暴露相关的唯一因素。需要进一步研究来评估手术因素并优化技术。